BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Weissenberger C, Geissler M, Otto F, Barke A, Henne K, Plehn GV, Rein A, Müller C, Bartelt S, Henke M. Anemia and long-term outcome in adjuvant and neoadjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: The Freiburg experience (1989-2002). World J Gastroenterol 2006; 12(12): 1849-1858 [PMID: 16609990 DOI: 10.3748/wjg.v12.i12.1849]
URL: https://www.wjgnet.com/1007-9327/full/v12/i12/1849.htm
Number Citing Articles
1
Rafał Stec, Lubomir Bodnar, Cezary Szczylik. Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysisJournal of Cancer Research and Clinical Oncology 2010; 136(2): 283 doi: 10.1007/s00432-009-0660-y
2
Robert Díaz Beveridge, Jorge Aparicio, Alejandro Tormo, Rafael Estevan, Josefina Artes, Alejandra Giménez, Ángel Segura, Susana Roldán, Rosana Palasí, David Ramos. Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experienceClinical and Translational Oncology 2012; 14(6): 471 doi: 10.1007/s12094-012-0826-y
3
M. R. Nowrousian. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology2008; : 207 doi: 10.1007/978-3-211-69459-6_8
4
Juha P. Väyrynen, Anne Tuomisto, Sara A. Väyrynen, Kai Klintrup, Toni Karhu, Jyrki Mäkelä, Karl-Heinz Herzig, Tuomo J. Karttunen, Markus J. Mäkinen. Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survivalScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-19572-y